QRG Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

QRG Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$542K	Sell	2,248 -100	-4%	-$21.9K	﹤0.01%	837
2026 Q1	$444K	Buy	2,348 +655	+39%	+$114K	﹤0.01%	827
2025 Q4	$288K	Buy	+1,693	New	+$260K	﹤0.01%	931
2024 Q2	–	Sell	-1,752	Closed	-$211K	–	1062
2024 Q1	$211K	Sell	1,752 -204	-10%	-$25K	﹤0.01%	1005
2023 Q4	$241K	Sell	1,956 -286	-13%	-$35.7K	﹤0.01%	938
2023 Q3	$290K	Buy	+2,242	New	+$299K	0.01%	822

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

QRG Capital Management's JAZZ Position: Q2 2026 in Review

QRG Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 4.3% in Q2 2026, selling an estimated $21.9K and leaving 2,248 shares worth $542K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

QRG Capital Management first reported a position in JAZZ in Q3 2023 and has held it in 6 quarters since. 105 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

QRG Capital Management held 2,248 shares of Jazz Pharmaceuticals worth $542K as of Q2 2026.
QRG Capital Management sold 100 Jazz Pharmaceuticals shares in Q2 2026, an estimated $21.9K.
Jazz Pharmaceuticals made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #837 holding.
QRG Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
105 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.